You are here

Valeant selling US$2.1b in assets to pay down debt


VALEANT Pharmaceuticals International Inc, the embattled Canadian drugmaker, has agreed to sell about US$2.1 billion in assets to get cash to streamline its businesses and begin easing its debt burden.

L'Oreal SA will pay Valeant US$1.3 billion for three skincare brands, the...

Market voices on: